Gender disparities in Parkinson's disease

Expert Review of Neurotherapeutics
Lisa M Shulman, Viveca Bhat

Abstract

Parkinson's disease is a chronic neurodegenerative disorder of unknown etiology. There are sparse data on gender differences in this disorder, but it is clear that there are gender discrepancies in incidence, symptoms, medication effects and treatments. There also appear to be lifecycle fluctuations in the disease course of female Parkinson's disease patients. The effect of estrogen in this disorder is multifold and its role in the development and treatment of PD will be discussed.

References

Dec 24, 1977·Lancet·P BedardA Villeneuve
Oct 1, 1990·Clinical Pharmacology and Therapeutics·B BoudíkováR Weinshilboum
Oct 1, 1989·Neurology·S C HoC M Lee
Jan 1, 1986·Movement Disorders : Official Journal of the Movement Disorder Society·N P Quinn, C D Marsden
May 1, 1982·Neurology·W C KollerN Biary
May 1, 1995·Neurology·N Giladi, S Honigman
Apr 1, 1994·Medical Hypotheses·D R SessionA C Kelly
Jun 1, 1997·Journal of Clinical Pharmacology·C E WrightG R Peters
Aug 1, 1997·American Journal of Obstetrics and Gynecology·T NaessenH C Larsen
May 26, 1998·European Journal of Pharmacology·K A DisshonD E Dluzen
Jun 20, 1998·Neurology·P C ThulinJ G Nutt
Apr 15, 1999·Clinical Neuropharmacology·E StrijksM W Horstink
May 5, 1999·Neurology·R Saunders-PullmanS Bressman
Jan 14, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·L M ShulmanW J Weiner
May 19, 2000·Parkinsonism & Related Disorders·G Hariz, M I Hariz
Jul 13, 2000·Acta Neurologica Scandinavica·B ScottS M Aquilonius
Aug 15, 2000·American Journal of Obstetrics and Gynecology·P J SchmidtD R Rubinow
Dec 5, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·H H Fernandez, K L Lapane
Jun 27, 2001·Journal of Neurocytology·E KüppersC Beyer
Dec 18, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·M D BenedettiW A Rocca
Mar 14, 2002·Archives of Neurology·V SenanarongJ L Cummings
May 1, 2002·Clinical Neuropharmacology·Mario ZappiaAldo Quattrone
Jun 5, 2002·Current Neurology and Neuroscience Reports·Oksana Suchowersky
Sep 3, 2002·Annals of Neurology·Miguel A HernánJuan J Gestal-Otero
Oct 2, 2002·Obstetrics and Gynecology Clinics of North America·Robert A Greene, Whitney Dixon
Nov 22, 2002·Advances in Neurology·Martin W I M HorstinkDean E Dluzen
Dec 3, 2002·The American Journal of Medicine·Deborah GradyElizabeth Barrett-Connor

❮ Previous
Next ❯

Citations

Nov 19, 2009·Journal of Neurology·Luigi Michele RomitoAlberto Albanese
Feb 5, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Carlos PenalozaZahra Zakeri
Dec 11, 2013·Translational Stroke Research·Lana J MawhinneyMichael C Lewis
Apr 9, 2013·Frontiers in Neuroendocrinology·Flavia di MichelePatrizia Longone
Dec 29, 2015·Neuroscience and Biobehavioral Reviews·Nadhir LitimThérèse Di Paolo
May 5, 2009·Frontiers in Neuroendocrinology·Mélanie BourqueThérèse Di Paolo
Jun 3, 2008·Molecular and Cellular Endocrinology·Marc MorissetteThérèse Di Paolo
Sep 29, 2007·Neuroscience·J L McDermott, D E Dluzen
Oct 16, 2007·The Journal of Steroid Biochemistry and Molecular Biology·M MorissetteT Di Paolo
Sep 11, 2007·Biochemical Pharmacology·Mélanie BourqueThérèse Di Paolo
Apr 11, 2007·Neuropharmacology·Marc MorissetteThérèse Di Paolo
Mar 13, 2014·Frontiers in Neuroendocrinology·Glenda E GilliesZahi Qamhawi
Jun 2, 2015·The International Journal of Biochemistry & Cell Biology·Hannah LokeJoohyung Lee
Oct 15, 2008·Neuroscience Letters·Chandani Lewis, Dean E Dluzen
Sep 7, 2014·European Psychiatry : the Journal of the Association of European Psychiatrists·D G Lichter, S G Finnegan
Feb 24, 2015·Neurobiology of Aging·Valtteri KaasinenMarko Seppänen
Jul 8, 2011·The International Journal of Neuropsychopharmacology·Caroline DavisJames L Kennedy
Aug 22, 2016·Journal of Neurology·Santosh K YadavMohammad Haris
Jun 23, 2018·ASN Neuro·T N SeyfriedJ S Schneider
Nov 8, 2013·American Journal of Physiology. Cell Physiology·Kalpit ShahNeil A Bradbury
Jun 6, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·Nobutaka HattoriAkihisa Mori
Nov 5, 2019·Human Genetics·Nirmal K SampathkumarBérénice A Benayoun
Jan 24, 2020·Movement Disorders Clinical Practice·Angus D Macleod, Carl E Counsell
Apr 3, 2008·Menopause International·Molly Daymont Price, Lisa M Shulman
Jan 10, 2021·Molecular Psychiatry·Nicole PetersenEdythe D London
Jan 16, 2021·European Journal of Pharmacology·Bhupesh VaidyaShyam Sunder Sharma
Sep 23, 2019·Behavioural Brain Research·Julia M MarquisCynthia A Kelm-Nelson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.